Full text is available at the source.
Abstract
Tirzepatide is associated with significant efficacy in lowering blood glucose levels and reducing body weight.
- Tirzepatide acts as a dual agonist of the GIP and GLP-1 receptors.
- Its increasing use is noted among patients with type 2 diabetes and obesity.
- Gastrointestinal symptoms are commonly recognized adverse effects of tirzepatide.
- Thyroid abnormalities are rare adverse effects linked to tirzepatide.
- A rare case of unilateral Graves' disease developed during tirzepatide treatment.
Simplified